Key result
Premature adrenarche linked to ~3-fold higher young adult insulin resistance, but not metabolic syndrome.
Why the study?
Premature adrenarche is associated with childhood overweight and hyperinsulinemia, but the long-term cardiometabolic outcome in adult women was unknown.
Does a history of premature adrenarche increase the prevalence of metabolic syndrome and cardiometabolic risk factors in young adult women compared to healthy controls?
Case-Control (n=71)
No
Does a history of premature adrenarche increase the prevalence of metabolic syndrome and cardiometabolic risk factors in young adult women compared to healthy controls?
Answers are grounded in this paper and cite their sources.
Premature adrenarche in girls does not increase the risk of adult metabolic syndrome, hypertension, dyslipidemia, or subclinical atherosclerosis, though it is associated with increased adult central adiposity and insulin resistance.
Context Premature adrenarche (PA) is associated with childhood overweight and hyperinsulinemia; the long-term cardiometabolic outcome is unknown. Objective To study cardiometabolic profile in adult women with previous PA. Design and participants Thirty women with PA and 41 control subjects were followed from prepuberty to young adulthood. Main outcome measures Prevalence of the metabolic syndrome (MetS) and clinical and biochemical cardiovascular risk factors. Results There were no differences in the prevalence of MetS or in any parameters indicating dyslipidemia, hypertension, hepatosteatosis, atherosclerosis, or low-grade inflammation between the study groups. However, prevalence of insulin resistance (IR; P = 0.014) and acanthosis nigricans (P = 0.010) was higher in the PA group. Neither fasting glucose nor insulin concentrations differed between the study groups, but HbA1c [adjusted for body mass index (BMI) P = 0.011] and Homeostatic Model Assessment of Insulin Resistance (P = 0.044; BMI-adjusted P = nonsignificant) were higher in the PA group. Although BMI and fat percentage were comparable between the study groups, the PA group had higher central fat mass than the control group. In the whole study population, MetS and IR were associated with greater adult fat mass, but no prepubertal factors predicting later IR were found. Conclusion PA does not seem to be associated with MetS, dyslipidemia, hypertension, atherosclerosis, or low-grade inflammation in young adult women. However, some women with PA may be at an increased risk of unfavorable glucose metabolism, which is associated with increased central adiposity at adult age rather than determined by prepubertal factors.
No takes yet. Share an insight, caveat, or question.
Liimatta et al. (2019) conducted a case-control in Premature adrenarche (n=71). History of premature adrenarche (PA) vs. Healthy age- and sex-matched control women without premature signs of androgen action was evaluated on Prevalence of insulin resistance (HOMA-IR > 2.94) at young adult age (p=0.014). Premature adrenarche was associated with higher young adult insulin resistance prevalence but no difference in metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: